Tharimmune Inc. (NASDAQ: THAR)
$4.16
+0.0900 ( +2.21% ) 18.6K
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
Market Data
Open
$4.16
Previous close
$4.07
Volume
18.6K
Market cap
$3.22M
Day range
$3.97 - $4.30
52 week range
$2.75 - $142.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 3 | Aug 30, 2023 |
pre | Proxies and info statements | 1 | Aug 18, 2023 |
10-q | Quarterly Reports | 48 | Aug 11, 2023 |
8-k | 8K-related | 12 | Jul 17, 2023 |
8-k | 8K-related | 15 | Jul 11, 2023 |